Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
TMRE Assay Kit: Documented Scope and Limits
2026-10-19
The APExBIO TMRE mitochondrial Membrane Potential Assay Kit (SKU K2233) is described as a fluorescence-based tool for assessing mitochondrial membrane potential (ΔΨm) using a Tetramethylrhodamine ethyl ester mitochondrial probe. Its documented signal is a proxy for membrane polarization, not an independent diagnosis of apoptosis or overall mitochondrial health.
-
TMRE Assay Kit: Mechanism and Evidence Boundaries
2026-10-19
APExBIO’s K2233 product description identifies TMRE as a potential-sensitive fluorescent probe and describes CCCP as a depolarization control. The mechanism supports mitochondrial membrane-potential measurement, but no identity-matched research paper is available here to establish product-specific performance, quantitative accuracy, or disease-model conclusions.
-
NLG1 Proteolysis, Social Memory, and Anisomycin
2026-10-18
A 2025 mouse study linked social interaction to secretase-dependent Neuroligin 1 cleavage, generation of an intracellular NLG1 fragment, cofilin regulation, and maintenance of social memory. The findings provide a mechanistic framework for memory persistence, but they do not establish a role for Anisomycin or JNK signaling in that pathway; supplier-described apoptosis applications should therefore be kept analytically separate.
-
2-NBDG Assay: What the Signal Can Establish
2026-10-17
APExBIO describes the 2-NBDG Glucose Uptake Assay Kit as a non-radioactive fluorescent assay for detecting uptake and intracellular retention of the glucose analogue 2-NBDG. The product information supports a defined measurement concept, but it does not provide identity-matched research data, independent validation, comparative effect sizes, or evidence that the signal directly measures glucose flux, lipid metabolism, or disease mechanisms.
-
SB705498: What the Record Documents
2026-10-16
The available APExBIO product entry identifies SB705498 by name and SKU A8519 but provides no documented mechanism, measurement principle, matched research paper, or study outcomes. The record therefore supports catalog-level identification only, not claims about molecular targets, pharmacology, assay performance, or clinical relevance.
-
Sodium Chloride B7288: Identity and Evidence Scope
2026-10-16
APExBIO identifies B7288 as sodium chloride, an inorganic salt with a stated molecular weight of 58.44, CAS number 7647-14-5, and 98% purity. The product information supports a conceptual role in ionic strength, osmotic balance, buffer preparation, and cell culture media, but no identity-matched study establishes product-specific performance, biological outcomes, or comparative effectiveness.
-
Genistein: Mechanism and Evidence Boundaries
2026-10-15
The APExBIO product description identifies Genistein as the isoflavonoid 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one and attributes protein tyrosine kinase inhibition, altered growth-factor signaling, and possible sex-steroid-receptor modulation to the compound. Reported micromolar IC50 and ED50 values provide assay-specific context, but the cited material does not supply an identity-matched research paper, sample sizes, uncertainty estimates, target-kinase identity, or complete experimental designs. The resulting evidence supports a hypothesis-generating overview of signal transduction and cancer chemoprevention research, not a general claim of selectivity, mechanism, or clinical efficacy.
-
4-Pentenoic Acid: Evidence and Scope
2026-10-15
The APExBIO product page identifies 4-Pentenoic acid (CAS 591-80-0) as a small organic acid with a terminal alkene and carboxylic acid group. It presents the compound as an organic acid building block, small molecule intermediate, and biochemical research reagent, but provides no identity-matched study establishing a biological mechanism, pathway effect, enzyme activity, or research outcome. The reported NMR and MS quality-control information supports product characterization, while the listed solubility and handling properties describe the material as supplied rather than its biological performance.
-
PI3K–Wnt Crosstalk in Pancreatic Cancer
2026-10-14
The 2025 pancreatic ductal adenocarcinoma study provides evidence that CDK4/6 inhibition can restrain proliferation while activating a GSK3β–Wnt/β-catenin program associated with epithelial-to-mesenchymal transition. GDC-0941 is mechanistically relevant as a vendor-described class I PI3K inhibitor, but it was not identified as a treatment in the cited study; therefore, links between PI3K inhibition and the reported PDAC phenotype remain interpretive rather than demonstrated.
-
Berbamine Hydrochloride and Ferroptosis in HCC
2026-10-14
Wang et al. identify a METTL16–SENP3–LTF axis associated with ferroptosis resistance and tumor progression in hepatocellular carcinoma. The supplied evidence does not establish that Berbamine hydrochloride, NF-κB signaling pathway inhibition, or the reported supplier-level potency values act through this axis.
-
Ibrutinib: Evidence and Research Boundaries
2026-10-13
PCI-32765, also called Ibrutinib, is described by APExBIO as a covalent BTK inhibitor relevant to B-cell receptor signaling inhibition. The supplied evidence supports a cautious conceptual role in chronic lymphocytic leukemia research and autoimmune disease models, but it does not establish clinical benefit, broad selectivity, or relevance to Alzheimer’s disease. The cited olive-biophenol study is mechanistically and experimentally distinct and should not be used to support claims about Ibrutinib.
-
KRas Transfer, Tunneling Nanotubes, and Cell Mechanics
2026-10-13
A 2024 Acta Biomaterialia study examined whether tunneling nanotubes can transfer mutant KRas between tumor cells and alter recipient-cell mechanics. The reported findings support a cell-level mechanistic link between KRas transfer, membrane properties, and invasive behavior, but the supplied record does not establish clinical relevance or therapeutic efficacy.
-
TMRE and Sodium-Linked Mitochondrial Dysfunction
2026-10-12
TMRE fluorescence provides a proxy for mitochondrial membrane potential, making it conceptually relevant to studies of mitochondrial depolarization, apoptosis, and sodium-associated energetic failure. The supplied Nature Communications report links sodium influx to mitochondrial metabolic disruption and necrotic cell death, but a TMRE signal alone cannot establish that complete causal pathway.
-
ISRIB and Forgetting: What Mouse Evidence Shows
2026-10-12
A source-grounded interpretation of a 2025 mouse study linking integrated stress response activity with natural and epilepsy-associated accelerated forgetting, with emphasis on causal limits, model applicability, and the distinction between ISR modulation and direct PERK inhibition.
-
G007-LK in Tankyrase and Cancer Research
2026-10-10
A source-grounded overview of G007-LK research, emphasizing tankyrase biology, Wnt and Hippo pathway findings, colorectal and liver cancer contexts, evidence strength, and translational limitations.